Healthcare Resource Utilization and Costs Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Contemporary US Claims

被引：0
|
作者：
Huntington, Scott F. [1 ]
Chang, Hsien-Yen [2 ]
Fu, Alex Z. [2 ,3 ]
Loefgren, Christina [4 ]
Lu, Xiaoxiao [5 ]
机构：
[1] Yale Univ, Div Hematol, New Haven, CT USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Georgetown Univ, Med Ctr, Washington, DC USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Janssen Sci Affairs LLC, Real World Value & Evidence, Horsham, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181909
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TREATMENT PRACTICE PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HRU), AND COSTS IN NEWLY DIAGNOSED PATIENTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA (TAML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC) IN A UNITED STATES (US) COMMERCIALLY INSURED POPULATION
    Hagiwara, M.
    Sharma, A.
    Chung, K. C.
    Delea, T. E.
    VALUE IN HEALTH, 2018, 21 : S27 - S27
  • [32] Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
    Ball, Brian J.
    Arslan, Shukaib
    Koller, Paul
    Ngo, Dat
    Afkhami, Michelle
    Salhotra, Amandeep
    Al-Malki, Monzr
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Otoukesh, Salman
    Amanam, Idoroenyi
    Pourhassan, Hoda
    Artz, Andrew
    Curtin, Peter
    Stein, Anthony
    Nakamura, Ryotaro
    Marcucci, Guido
    Smith, Eileen
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3232 - 3236
  • [33] A retrospective study of comorbidities and complications in elderly acute myeloid leukemia (AML) patients in the US
    Dhopeshwarkar, Neil
    Wang, Xuehong
    Iqbal, Shahed
    Salas, Maribel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Pooled clinical safety analysis of CPX-351 versus conventional chemotherapy in patients with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML)
    Cortes, Jorge E.
    Ryan, Robert J.
    Louie, Arthur C.
    Chiarella, Michael
    Uy, Geoffrey L.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 158 - 158
  • [35] Healthcare resource utilization in a phase 3 study of CPX-351 in patients with newly diagnosed high-risk/secondary acute myeloid leukemia
    Villa, Kathleen F.
    Ryan, Robert J.
    Chiarella, Michael
    Louie, Arthur C.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 714 - 720
  • [36] Treatment outcomes and healthcare resource utilization (HRU) among patients with acute myeloid leukemia (AML) ineligible for intensive chemotherapy in US community oncology setting.
    Lyons, Roger M.
    Potluri, Jalaja
    Bui, Cat
    Choi, Michelle E.
    Ma, Esprit
    Svensson, Anders
    Davies, Kalatu
    Annavarapu, Srinivas
    Kapustyan, Tatyana
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
    Todisco, Elisabetta
    Papayannidis, Cristina
    Fracchiolla, Nicola
    Petracci, Elisabetta
    Zingaretti, Chiara
    Vetro, Calogero
    Martelli, Maria Paola
    Zappasodi, Patrizia
    Di Renzo, Nicola
    Gallo, Susanna
    Audisio, Ernesta
    Griguolo, Davide
    Cerchione, Claudio
    Selleri, Carmine
    Mattei, Daniele
    Bernardi, Massimo
    Fumagalli, Monica
    Rizzuto, Giuliana
    Facchini, Luca
    Basilico, Claudia Maria
    Manfra, Ilenia
    Borlenghi, Erika
    Cairoli, Roberto
    Salutari, Prassede
    Gottardi, Michele
    Molteni, Alfredo
    Martini, Vincenza
    Lunghi, Monia
    Fianchi, Luana
    Cilloni, Daniela
    Lanza, Francesco
    Abruzzese, Elisabetta
    Cascavilla, Nicola
    Rivellini, Flavia
    Ferrara, Felicetto
    Maurillo, Luca
    Nanni, Jacopo
    Romano, Alessandra
    Cardinali, Valeria
    Gigli, Federica
    Roncoroni, Elisa
    Federico, Vincenzo
    Marconi, Giovanni
    Volpi, Roberta
    Sciume, Mariarita
    Tarella, Corrado
    Rossi, Giuseppe
    Martinelli, Giovanni
    CANCER, 2023, 129 (07) : 992 - 1004
  • [38] Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims Data
    Marie Schild
    Valeria Weber
    Diamant Thaçi
    Agnes Kisser
    Wolfgang Galetzka
    Dirk Enders
    Franziska Zügel
    Christoph Ohlmeier
    Holger Gothe
    Dermatology and Therapy, 2022, 12 : 1925 - 1945
  • [39] Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims Data
    Schild, Marie
    Weber, Valeria
    Thaci, Diamant
    Kisser, Agnes
    Galetzka, Wolfgang
    Enders, Dirk
    Zuegel, Franziska
    Ohlmeier, Christoph
    Gothe, Holger
    DERMATOLOGY AND THERAPY, 2022, 12 (08) : 1925 - 1945
  • [40] A phase I study of ENMD-2076 in patients with relapsed or refractory acute myeloid leukemia (AML)
    Yee, Karen W.
    Brandwein, Joseph
    Minden, Mark D.
    Sanfelice, Deborah
    Chow, Sue
    Hedley, David W.
    Schimmer, Aaron D.
    Schuh, Andre C.
    Gupta, Vikas
    Sidor, Carolyn F.
    Arnott, Jamie
    Fletcher, Graham
    Bray, Mark
    Chen, Hsiao-Wei Tina
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345